Share-based Payment Arrangements | (2) Share-based Payment Arrangements As of September 24, 2022, the Company has an employee equity incentive plan, the 2011 equity incentive plan (the “2011 EIP”). The Company also has a stock compensation plan for members of its Board of Directors, the 2022 Directors Stock Compensation Plan (the “2022 DSCP”), which replaced the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated, the “2013 DSCP”). At the Company’s 2022 Annual Meeting of Stockholders held on May 11, 2022, the Company’s stockholders approved the 2022 DSCP. The provisions of the 2022 DSCP are substantially similar to the provisions of the 2013 DSCP. 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP, and 200,000 shares of the Company’s common stock were authorized for issuance under the 2022 DSCP. No further grants can be made under the 2013 DSCP, including 56,502 shares of the Company’s common stock previously reserved for issuance, but not issued, under the 2013 DSCP. The 2011 EIP, 2013 DSCP and 2022 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands): Thirty Nine Weeks Ended Thirteen Weeks Ended September 24, 2022 September 25, 2021 September 24, 2022 September 25, 2021 Total cost of the Plans during the period $ 9,409 $ 18,717 $ 3,599 $ 7,824 Amount of related income tax benefit recognized during the period (5,219 ) (5,636 ) (949 ) (1,919 ) Net cost of the Plans during the period $ 4,190 $ 13,081 $ 2,650 $ 5,905 Included in income tax benefits recognized in the thirty-nine-week periods ended September 24, 2022 and September 25, 2021 were excess tax benefits from stock-based awards of $2,910,000 and $1,039,000 respectively. As of September 24, 2022, there were 193,217 shares of the Company’s common stock reserved for issuance under the 2022 DSCP and 3,245,251 shares of the Company’s common stock reserved for issuance under the 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date Outstanding at December 25, 2021 209,399 $ 102.90 Granted 49,825 $ 139.54 Shares earned in excess of target (1) 91,497 $ 92.58 Vested shares, including shares earned in excess of target (177,146 ) $ 95.48 Forfeited (21,989 ) $ 113.85 Outstanding at September 24, 2022 151,586 $ 115.80 (1) Represents additional shares earned under each of the February 2, 2017 , , under each such award. During the thirty-nine-week period ended September 24, 2022, the Company granted RSUs with a performance condition. Outstanding RSUs at both December 25, 2021 and September 24, 2022 include RSUs with a performance condition and RSUs with a market condition, as further described below and in the Company’s 2021 Annual Report on Form 10-K. RSUs with a performance condition granted on January 28, 2022 may vest on January 31 of 2025, 2026 and 2027 based on growth in operating income and pre-tax The Company recognized approximately $7,035,000 and $16,223,000 of share-based compensation expense related to RSU awards in the thirty-nine-week periods ended September 24, 2022 and September 25, 2021, respectively. As of September 24, 2022, there was a maximum of $19.7 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.6 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results. Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 56,436 $ 125.16 Granted 25,354 $ 152.54 Vested (27,074 ) $ 122.68 Forfeited (6,921 ) $ 144.45 Non-vested 47,795 $ 138.30 The fair value of each share of non-vested non-vested As of September 24, 2022, there was $4,375,000 of total unrecognized compensation cost related to non-vested non-vested Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Number of Weighted Average Weighted Average Aggregate Intrinsic Options outstanding at December 25, 2021 8,570 $ 55.42 Exercised (4,100 ) $ 54.36 Options outstanding at September 24, 2022 4,470 $ 56.40 0.4 $ 386 Options exercisable at September 24, 2022 4,470 $ 56.40 0.4 $ 386 The total intrinsic value of stock options exercised during the thirty-nine-week periods ended September 24, 2022 and September 25, 2021 was $429,000 and $644,000, respectively. As of September 24, 2022, there was no unrecognized compensation cost related to stock options granted under the Plans. |